In this study, a ‘MiniCoopR’ screening strategy was developed that utilized a strain in which a mitfa loss-of-function mutation was introduced into a tumor-prone Tg(mitfa:BRAFV600E); p53(lf) background. This evidence concerns the gene TP53 and neoplasm.